DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Thoratec Corporation (THOR)
« Back to company indexTHOR Chatter Timeline
Stock Ticker for THOR
Most Active Tweeters for THOR
| User | Tweets |
|---|---|
| @AmericanBanking | 2 |
| @TickerReport | 1 |
| @MSollender | 1 |
| @Gambiste1 | 1 |
| @brendan_49 | 1 |
Recent Tweets for THOR
 |
@WilliamGerber1 $ASND R&D Day, just presented on their development of safer IL-2 product (beta / gamma) for cancers. $THOR June 26th 2019, 12:06pm |
 |
@dakotafinancial Analysts Set $26.67 Price Target for Synthorx Inc $THOR https://t.co/UXjS9TQswy June 25th 2019, 3:06pm |
 |
@Gambiste1 RT @MSollender: @Sanctuary_Bio $THOR Synthorx hasn't yet, I think at IPO they weren't in clinic June 19th 2019, 5:06pm |
 |
@MSollender @Sanctuary_Bio $THOR Synthorx hasn't yet, I think at IPO they weren't in clinic June 19th 2019, 1:06pm |
 |
@AmericanBanking Short Interest in Synthorx Inc $THOR Declines By 7.8% https://t.co/mmyG7iJ717 #stocks June 19th 2019, 9:06am |
|
@AmericanBanking Analysts Expect Synthorx Inc $THOR to Post -$0.38 Earnings Per Share https://t.co/Nqovi8sE1R #stocks June 18th 2019, 6:06pm |
 |
@TickerReport Synthorx Inc $THOR Given $26.67 Average Price Target by Analysts https://t.co/uAVmjvuRi0 June 18th 2019, 6:06pm |
 |
@AlertTrade TREND REVERSAL UP ALERT: $THOR Synthorx, Inc. Common Stock ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room June 17th 2019, 4:06pm |
 |
@WKRBNews Synthorx $THOR Trading Down 1.7% https://t.co/LEmrvzObQc #markets June 16th 2019, 4:06am |
 |
@brendan_49 $THOR 10-K contains a fascinating history of IL-2 drug development. Worth a read even if you won’t consider the shares. June 13th 2019, 3:06pm |
 |
@OlympiaReport Brokerages Expect Synthorx Inc $THOR to Post -$0.38 Earnings Per Share https://t.co/WncjBq43Ns June 10th 2019, 8:06pm |
 |
@InsiderAlertsIA $THOR: New Insider Filing on Director FLOYD ROMESBERG: https://t.co/6MtjDextrg June 10th 2019, 7:06pm |
 |
@filingsdb New Form 8-K filed by Synthorx, Inc. $THOR - https://t.co/kwyTC21J0I June 10th 2019, 4:06pm |
 |
@marko1332 @buysidebio Waiting to see where the bottom is with $THOR June 9th 2019, 3:06pm |
 |
@Felibertc RT @fortivus: Super Trade! $THOR momentum trade for stress free profit! #Trading #stocks #nyse https://t.co/spSFHAqXJA June 9th 2019, 10:06am |
 |
@fortivus Super Trade! $THOR momentum trade for stress free profit! #Trading #stocks #nyse https://t.co/spSFHAqXJA June 8th 2019, 1:06pm |
 |
@dailypoliticaln Brokerages Anticipate Synthorx Inc $THOR to Post -$0.38 EPS https://t.co/eF4Tf3fdH2 June 8th 2019, 11:06am |
 |
@CashyStocks Super Trade! $THOR momentum trade for stress free profit!: https://t.co/Kx2nMBr6e6 #stocks #trading #nyse June 7th 2019, 7:06pm |
 |
@tradnews_ RT @AlertTrade: Trading Ideas: $THOR So bad it may be good, Reversal trade into earnings https://t.co/TwytnaQz6O ? FREE trade-of-week via ?… June 7th 2019, 3:06pm |
|
@AlertTrade Trading Ideas: $THOR So bad it may be good, Reversal trade into earnings https://t.co/TwytnaQz6O ? FREE trade-of-we… https://t.co/YAS9hFG0SG June 7th 2019, 3:06pm |
 |
@ConsumerFeed Analysts Expect Synthorx Inc $THOR to Post -$0.38 Earnings Per Share https://t.co/I4sZIzusr6 June 6th 2019, 8:06am |
 |
@TranscriptDaily Synthorx Inc’s $THOR Lock-Up Period To End Tomorrow https://t.co/ywBX2f12Vn June 4th 2019, 1:06am |
|
@AmericanBanking Zacks: Synthorx Inc $THOR Receives Average Rating of “Strong Buy” from Brokerages https://t.co/sIbWYxf3Vn #stocks June 3rd 2019, 8:06pm |
 |
@ZolmaxNews Brokerages Set $26.67 Target Price for Synthorx Inc $THOR https://t.co/qXp2fVx6u3 June 3rd 2019, 8:06pm |
 |
@ThisLincolnian Synthorx Inc’s $THOR Lock-Up Period Will End on June 5th https://t.co/n4nDGE0Wg5 June 2nd 2019, 1:06am |
 |
@nycdoc29 RT @dt_bio: #synbio meets #oncology at #asco19. Non-canonical base pairs now being used to incorporate new amino acids into IL2. $THOR is s… June 1st 2019, 6:06pm |
 |
@confcalltran Thoratec: Using Synthetic Biology To Reprogram The Therapeutic Activity Of Interleukin-2 (IL-2) https://t.co/woKtsXpPOo $THOR May 31st 2019, 4:05pm |
|
@filingsdb New Form 8-K filed by Synthorx, Inc. $THOR - https://t.co/zG1hbncIdM May 31st 2019, 4:05pm |
|
@OlympiaReport Synthorx Inc’s Lock-Up Period Set To Expire on June 5th $THOR https://t.co/vSqudn447M May 31st 2019, 1:05am |
|
@AmericanBanking Synthorx Inc’s Lock-Up Period Set To End on June 5th $THOR https://t.co/8FsBsCWH2I #stocks May 29th 2019, 1:05am |
 |
@WeekHerald Synthorx Inc’s Lock-Up Period Set To End on June 5th $THOR https://t.co/XsNtYhDT7u May 29th 2019, 1:05am |
 |
@GatorTrader1983 Super Trade! $THOR momentum trade for stress free profit!: https://t.co/ZJYgpkSRIo #stocks #trading #nyse May 28th 2019, 6:05am |
 |
@femca2 Some projects I bought last 2 year. Scam or shutdown: $OCL $THOR Unable to follow thier road map and digging new lo… https://t.co/Nb7NNGVPs0 May 26th 2019, 8:05pm |
 |
@bulletin_en Reviewing Synthorx Inc. $THOR's and Its Rivals results https://t.co/NW639KrZYo May 23rd 2019, 11:05am |
|
@TranscriptDaily Zacks: Analysts Set $26.67 Target Price for Synthorx Inc $THOR https://t.co/plDBJWg8Ox May 21st 2019, 9:05am |
|
@AmericanBanking Synthorx Inc $THOR Receives Average Recommendation of “Strong Buy” from Analysts https://t.co/iTkuS7a92N #stocks May 18th 2019, 6:05pm |
|
@bulletin_en Reviewing Harpoon Therapeutics Inc. $THOR's results https://t.co/DHRC29xcNl May 17th 2019, 9:05pm |
|
@bulletin_en Contrasting of Editas Medicine Inc. $THOR https://t.co/enjoNKkYXC May 17th 2019, 5:05pm |
 |
@FinZTribune ACADIA Pharmaceuticals Inc. $THOR Comparing side by side https://t.co/lK9dAikLDi May 16th 2019, 7:05pm |
 |
@HottestStockNow $THOR to reveal preclinical findings on its THOR-707 for the treatment of solid tumors https://t.co/9kr0nnrYTB May 15th 2019, 10:05pm |
 |
@StockTexts $THOR Synthorx to Present at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Nasdaq:THOR https://t.co/OmQwAhj6yl May 15th 2019, 5:05pm |
|
@bulletin_en Reviewing ImmunoCellular Therapeutics Ltd. $THOR's results https://t.co/draLrB2iWA May 14th 2019, 9:05pm |
|
@bulletin_en RedHill Biopharma Ltd. $THOR https://t.co/zMi4FmGVvr May 11th 2019, 11:05am |
 |
@ChartMill $THOR has a Quick Ratio of 22.15, indicating it is financially healthy. https://t.co/bPZJlUCxZa https://t.co/Up3BlLoQfn May 11th 2019, 1:05am |
 |
@macondailynews Brokerages Set $26.67 Target Price for Synthorx Inc $THOR https://t.co/aBQOiczWhy May 10th 2019, 11:05pm |
|
@FinZTribune Regeneron Pharmaceuticals Inc. $THOR Comparison side by side https://t.co/BQhb9poi54 May 9th 2019, 10:05pm |
 |
@stocknewstimes Zacks: Synthorx Inc $THOR Given $26.67 Average Target Price by Analysts https://t.co/lVq1fa8vY1 May 8th 2019, 5:05pm |
 |
@SleekMoneycom Zacks: Synthorx Inc $THOR Given $26.67 Average Target Price by Analysts https://t.co/24zKCl5UBK #investing May 8th 2019, 5:05pm |
|
@TranscriptDaily Jefferies Financial Group Brokers Reduce Earnings Estimates for Synthorx Inc $THOR https://t.co/w1Z45HrmbR May 8th 2019, 1:05am |
|
@ChartMill Although the technical rating is bad, $THOR does present a nice setup opportunity. https://t.co/0V6S85vsLS https://t.co/XiMLYHCOd7 May 6th 2019, 8:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.